Description
MORE DETAILS ABOUT PRODUCT
Primary Use: Prescribed for the treatment of bacterial infections caused by susceptible microorganisms.
How It Works: Ceftriaxone interferes with bacterial cell wall synthesis, helping stop bacterial growth.
Beta-Lactamase Inhibition: Sulbactam inhibits certain beta-lactamase enzymes that can reduce the activity of some antibiotics.
Antibacterial Action: Provides antibacterial activity against susceptible organisms.
Infection Management: May be prescribed for different bacterial infections based on clinical evaluation.
Combination Formulation: Combines Ceftriaxone and Sulbactam in one injectable formulation.
Active Ingredients: Ceftriaxone and Sulbactam.
Strength: Combined strength of 1.5 gm.
Dosage Form: Sterile powder for injection.
Administration: For intramuscular or intravenous use.
Diluent: Supplied with 10 ml Sterile Water for Injections IP.
Dosage: Must be determined by a qualified healthcare professional according to the patient’s condition.
Preparation: Reconstitution should be performed by trained medical personnel using the appropriate instructions.
Indications
Key Benefits of Ceftranote-S 1.5 Injection
Combination Antibiotic Formulation: Combines Ceftriaxone and Sulbactam in a single injectable formulation.
Broad Antibacterial Coverage: Provides activity against a range of susceptible bacterial organisms.
Bacterial Cell Wall Inhibition: Ceftriaxone works by interfering with bacterial cell wall synthesis.
Beta-Lactamase Inhibitor Support: Sulbactam helps inhibit certain beta-lactamase enzymes produced by bacteria.
Complementary Action: Combines two active ingredients with different roles in antibacterial therapy.
Bacterial Infection Management: May be prescribed for susceptible bacterial infections following medical evaluation.
Injectable Dosage Form: Designed for administration through intramuscular or intravenous routes.
1.5 gm Combined Strength: Provides the labelled combined strength in a single vial.
Supplied Diluent: Comes with 10 ml Sterile Water for Injections IP.
Clinical Use: Suitable for use in appropriate healthcare settings under medical supervision.
Targeted Antibiotic Therapy: Supports treatment selection based on bacterial susceptibility.
Convenient Vial Packaging: Provides the medicine in a single-dose vial.
Professional Administration: Intended to be prepared and administered by trained healthcare personnel.
Established Active Ingredients: Contains Ceftriaxone and Sulbactam, commonly used together in combination antibiotic therapy.
Prescription-Based Treatment: Allows healthcare professionals to select and monitor antibiotic therapy according to the patient’s condition.
Consistent Formulation: Provides a standardized combination of two active pharmaceutical ingredients.
Parenteral Delivery: Allows the medicine to be administered directly into the body through prescribed injectable routes.
Medical Treatment Flexibility: Enables healthcare professionals to consider the combination when selecting appropriate antibiotic therapy.
Controlled Clinical Administration: Supports supervised dosing and monitoring in hospitals and other suitable healthcare facilities.




Reviews
There are no reviews yet.